Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Gilead
Gilead
Page 3 of 4
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By
News Correspondent
December 19, 2017
Health
PHOTOS: The Incredible Advances We’ve Made in the War Against HIV on World AIDS Day
By
News Correspondent
December 1, 2017
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By
Investment Desk
November 16, 2017
Health
The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By
Market Analyst
October 19, 2017
Health
Gilead’s Deal to Buy Kite Pharma Is a Game-Changer
By
Crypto Correspondent
August 28, 2017
Health
The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By
Digital Assets Editor
August 3, 2017
Health
Gilead Just Paid $125 Million to Nab a Big Market Advantage
By
Investment Desk
February 21, 2017
Health
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By
Senior Editor
January 7, 2017
Health
Why GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead
By
Digital Assets Editor
December 21, 2016
Health
Merck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By
Tech Reporter
December 16, 2016
Finance
Wells Fargo’s John Stumpf Is the Latest Victim of ‘CEO of the Year’ Curse
By
Investment Desk
October 14, 2016
Why the Fight Against AIDS Still Matters, in One Chart
By
Editorial Team
August 23, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Blockchain Reporter
August 1, 2016
Health
The First-Ever Drug to Treat All Major Hep C Strains Just Got Approved
By
Investment Desk
June 29, 2016
Health
Why Gilead May Not Have to Pay Merck $200 Million After All
By
Tech Reporter
June 7, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer
Economy
The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
By
Tech Reporter
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Staff Writer